Who owns elanco

Investing Best Accounts. Stock Market Basics. Stock Market. Industries to Invest In. Getting Started. Planning for Retirement. Retired: What Now? Personal Finance. Credit Cards. About Us. Who Is the Motley Fool? Fool Podcasts. New Ventures. Search Search:. Jul 19, at AM. His investing interests include tech, consumer, and event-driven situations. You may opt-out by clicking here. More From Forbes. Nov 11, , am EST.

Edit Story. Jun 25, , am EDT. Trefis Team Contributor. By Taylor Tepper. Trefis Team. In particular, it provides Elanco with a greater commercial presence in the companion animal and swine markets, expands Elanco's presence in the equine and vaccines areas, and creates an entry into the aquaculture market.

Best of all, it will enable Elanco to better fulfill our important mission of enriching people's lives through safe, nutritious, affordable food and healthier pets. And that directly supports Lilly's mission to make life better for people around the world. Goldman Sachs is acting as financial advisor to Novartis and Freshfields Bruckhaus Deringer is acting as Novartis' legal counsel. Lilly will conduct a conference call with the investment community and media today at a.

EDT to discuss today's announcement. Investors, media and the general public can access a live webcast of the conference call through a link that will be posted on the investor section of Lilly's website at www. The webcast of the conference call will be available for replay via the website. The innovative, high-quality medicines of Novartis Animal Health contribute to the quality of life, health and welfare of animals around the world.

For pets, their products are effective aids to treat some internal and external parasites, prevent heartworm and flea infestations and treat ailments such as arthritic pain and kidney, heart and allergic diseases. For farm animals, they offer therapeutic products to treat parasitic and bacterial diseases and are also continually developing new vaccines to prevent diseases in livestock and farmed fish. Specific needs of food producers in the area of farm bioprotection are met by providing innovative fly control products and services.

Elanco is a global, innovation-driven company that develops and markets products and services to improve animal health and protein production in more than 75 countries. Elanco employs more than 3, people worldwide, with offices in more than 40 countries, and is a division of Eli Lilly and Company , a leading global pharmaceutical corporation.

Additional information about Elanco is available at www. Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world.